Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Antonis A Manolis,1 Theodora A Manolis,2 Helen Melita,3 Antonis S Manolis4 1Patras University School of Medicine, Patras, Greece; 2Red Cross Hospital, Athens, Greece; 3Onassis Cardiac Surgery Center, Athens, Greece; 4Athens University School of Medicine, Athens, GreeceCorrespondence: Antonis S Manol...

Full description

Bibliographic Details
Main Authors: Manolis AA, Manolis TA, Melita H, Manolis AS
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Vascular Health and Risk Management
Subjects:
spironolactone
mineralocorticoid receptor antagonists
spironolactone oral suspension
heart failure
heart failure with reduced ejection fraction
heart failure with preserved ejection fraction
sudden cardiac death
hyperkalemia
gynecomastia
renal failure
Online Access:https://www.dovepress.com/spotlight-on-spironolactone-oral-suspension-for-the-treatment-of-heart-peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/spotlight-on-spironolactone-oral-suspension-for-the-treatment-of-heart-peer-reviewed-article-VHRM

Similar Items